FDA Accepts Biohaven’s Resubmitted Drug Application for Review
Biohaven said the FDA accepted its resubmitted New Drug Application for an experimental rare-disease drug.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.